Merrimack Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
MACK Nasdaq 8731 http://www.merrimackpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Merrimack Pharmaceuticals Inc

Options Traders Expect Huge Moves in Merrimack Pharmaceuticals (MACK) Stock - Jun 15th, 2018 6:41 am
Why is Merrimack (MACK) Up 6.3% Since Its Last Earnings Report? - Jun 7th, 2018 7:15 am
Edited Transcript of MACK earnings conference call or presentation 8-May-18 12:30pm GMT - Jun 4th, 2018 11:57 am
Research Report Identifies AngioDynamics, Kaiser Aluminum, Mammoth Energy Services, Meridian Bioscience, Merrimack Pharmaceuticals, and Energizer with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement - May 29th, 2018 6:15 am
Merrimack to Present at the 2018 American Society of Clinical Oncology Annual Meeting - May 29th, 2018 5:00 am
Merrimack (MACK) Reports Wider-Than-Expected Loss in Q1 - May 9th, 2018 8:49 am
Merrimack Reports First Quarter 2018 Financial Results - May 8th, 2018 4:25 am
What's in the Cards for Merrimack (MACK) in Q1 Earnings? - May 3rd, 2018 8:13 am
Merrimack Announces Timing of First Quarter 2018 Investor Conference Call - May 1st, 2018 5:00 am
Merrimack to Present Preclinical Data at the 2018 American Association for Cancer Research Annual Meeting - Apr 9th, 2018 5:30 am
Consolidated Research: 2018 Summary Expectations for Merrimack Pharmaceuticals, Monroe Capital, NL Industries, FCB Financial, Amtech, and Otter Tail — Fundamental Analysis, Key Performance Indications - Apr 4th, 2018 6:15 am
Wired News – Merrimack Expanded Enrollment in Ongoing Randomized Phase-2 SHERLOC Trial of MM-121 in Non-Small Cell Lung Cancer - Mar 14th, 2018 5:30 am
Merrimack (MACK) Incurs Narrower-Than-Expected Loss in Q4 - Mar 13th, 2018 7:45 am
Edited Transcript of MACK earnings conference call or presentation 12-Mar-18 12:30pm GMT - Mar 12th, 2018 5:06 pm
Merrimack Pharmaceuticals, Inc. to Host Earnings Call - Mar 12th, 2018 5:30 am
Merrimack Provides Business Update and Reports 2017 Financial Results - Mar 12th, 2018 4:27 am
Merrimack Strengthens SHERLOC Study of MM-121 in Non-small Cell Lung Cancer - Mar 12th, 2018 4:25 am
Merrimack Announces Timing of Full Year 2017 Investor Conference Call and Presentation at the Cowen Health Care Conference - Mar 5th, 2018 5:00 am
Are Earnings Prospects Improving For Loss-Making Merrimack Pharmaceuticals Inc’s (NASDAQ:MACK)? - Feb 27th, 2018 3:11 am
Merrimack Doses First Patient in Randomized Phase 2 Clinical Study of MM-121 in Patients with Post-Menopausal Metastatic Breast Cancer - Feb 26th, 2018 4:55 am